Document Detail

Effect of sucralfate and cimetidine on rheumatoid patients with active gastroduodenal lesions who are taking nonsteroidal anti-inflammatory drugs. A pilot study.
MedLine Citation:
PMID:  2735335     Owner:  NLM     Status:  MEDLINE    
In a pilot study, 26 rheumatoid arthritic patients taking continuous, stable dosage regimens of nonsteroidal anti-inflammatory drugs and with developed gastric and duodenal lesions were administered sucralfate 1 g four times per day (14 patients) or cimetidine 400 mg twice daily (12 patients) in a single-blind regimen for six weeks. Eleven of the patients given sucralfate and eight of the patients taking cimetidine had improved lesion scores. The lesion score of 10 of the 14 patients taking sucralfate and four of the 12 patients taking cimetidine improved by 50 percent or better (not significant). The antrum and body of the gastric mucosa and the mucosa of the duodenum synthesized prostanoids and thromboxane A2, and there was no significant difference in the synthesis of individual prostanoids at entry to the trial in the groups assigned to sucralfate or cimetidine. After six weeks of administration of sucralfate, prostaglandin E2 (PGE2) synthesis by the antrum and body, but not the duodenum, was significantly greater than observed in the biopsy specimens at entry despite continuation of non-steroidal anti-inflammatory drug therapy. After six weeks of cimetidine treatment, no change in PGE2 synthesis was noted in any biopsy specimens when compared with the synthesis at entry. No change in the synthesis of PGF2 alpha, 6-oxo-PGF1 alpha, or thromboxane B2 was noted in gastric or duodenal biopsy specimens in any treatment group. Sucralfate and cimetidine administration resulted in improved gastroduodenal lesion scores in rheumatoid arthritic patients continuing with nonsteroidal anti-inflammatory drug therapy.
H A Shepherd; D Fine; K Hillier; R Jewell; N Cox
Related Documents :
15645645 - Gastric dysmotility associated with accumulation of mitochondrial a3243g mutation in th...
20082665 - Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to de...
11288845 - Spontaneous volume changes in gastric banding devices: complications of a semipermeable...
15968415 - Is normal gastric emptying a predictor of normal gastric function?
8179975 - Hypokalaemia in the elderly: is it always diuretic-induced?
22425715 - Frontal lobe epilepsy with atypical seizure semiology resembling shuddering attacks or ...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of medicine     Volume:  86     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1989 Jun 
Date Detail:
Created Date:  1989-07-21     Completed Date:  1989-07-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  49-54     Citation Subset:  AIM; IM    
Royal Hampshire County Hospital, Winchester, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Arthritis, Rheumatoid / complications,  drug therapy*
Cimetidine / therapeutic use*
Duodenum / metabolism
Gastric Mucosa / metabolism
Intestinal Mucosa / metabolism
Middle Aged
Peptic Ulcer / complications,  drug therapy*,  metabolism,  pathology
Pilot Projects
Prostaglandins / biosynthesis
Random Allocation
Sucralfate / therapeutic use*
Thromboxane B2 / biosynthesis
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Prostaglandins; 51481-61-9/Cimetidine; 54182-58-0/Sucralfate; 54397-85-2/Thromboxane B2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of food and sucralfate on the pharmacokinetics of naproxen and ketoprofen in humans.
Next Document:  Sucralfate interactions with gastric mucus.